You are using an outdated browser. We suggest you update your browser for a better experience.
Click here
for update.
Close this notification.
Skip to main content
Skip to search
Cancer Care Ontario
Ontario Renal Network
EN
FR
Recently Viewed
Cancer Care Ontario
Open Navigation
Close Navigation
Home
Types of Cancer
Cancer Treatments
Get Checked for Cancer
Find Services
Indigenous
Ontario Cancer Plan
COVID-19
Drug Formulary
Drugs
Regimens
Funding & Reimbursement
Side Effects
Drug Safety & Information
Pre-Printed Orders
What’s New
Guidelines & Advice
Browse Guidelines
Types of Cancer
Modality of Care
Cancer Continuum
Most Popular Documents
What’s New in Guidelines & Advice
About Guidelines
Toolkits
Education & Events
Managing Symptoms
COVID-19 Resources
Pathway Maps
Browse Pathway Maps
Bladder Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Endometrial Cancer
Esophageal Cancer
Lung Cancer
Oropharyngeal Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Soft Tissue Sarcoma
Thyroid Cancer
Cervical Lymphadenopathy in Adults
Hepatocellular Cancer
Thymic Cancer
Data & Research
Accessing Data
View Data
Submitting Data
Our Research
Funding Opportunities
Open Search
Close Search
Open Navigation
Close Navigation
All
Drug Formulary
Guidelines and Advice
Data
Cancer Care Ontario
General Cancer Info
Pathway Maps
Sort by
Most Relevant
Letter (A-Z)
Most Recent
You are here
Search
You may filter this list by entering a keyword to the right
Refine Your Results
161 Results
Regimen
PGLDX
Cancer Type:
Breast
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Palliative
Drugs Used:
pegylated liposomal DOXOrubicin
(Compassionate)
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2025
Regimen
PEMB; CISP(RT-W)+PEMB
Cancer Type:
Gynecologic,
Cervix
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Adjuvant, Curative
Drugs Used:
pembrolizumab
(Unfunded)
,
CISplatin
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
May 2025
Regimen
PACL
Cancer Type:
Breast
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Palliative
Drugs Used:
PACLitaxel
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2024
Regimen
PGLDX
Cancer Type:
Sarcoma,
Kaposi's Sarcoma
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Palliative
Funding:
New Drug Funding Program
Liposomal Doxorubicin - HIV-positive Kaposi's Sarcoma
Show More
Show more tags
, Show Less
Show fewer tags
Drugs Used:
pegylated liposomal DOXOrubicin
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2025
Prostate Cancer Pathway Map
Regimen
PACL(W)+RAMU
Cancer Type:
Gastrointestinal,
Esophagus,
Gastric / Stomach
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Palliative
Funding:
New Drug Funding Program
Ramucirumab - Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Show More
Show more tags
, Show Less
Show fewer tags
Drugs Used:
ramucirumab
,
PACLitaxel
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2023
Regimen
PNTM
Cancer Type:
Gastrointestinal,
Colorectal,
Small bowel and appendix
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Palliative
Funding:
New Drug Funding Program
Panitumumab - Metastatic Colorectal Small Bowel or Appendiceal Cancer
Show More
Show more tags
, Show Less
Show fewer tags
Drugs Used:
PANitumumab
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2023
Regimen
PAD/VCD
Cancer Type:
Hematologic,
Multiple Myeloma
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Palliative
Funding:
New Drug Funding Program
Bortezomib - Previously Untreated - Multiple Myeloma Pre-Stem Cell Transplant
ODB - General Benefit
dexamethasone
ODB - General Benefit
cyclophosphamide - oral tablets
Show More
Show more tags
, Show Less
Show fewer tags
Drugs Used:
bortezomib
,
pegylated liposomal DOXOrubicin
(Unfunded)
,
dexamethasone
,
cyclophosphamide
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Sep 2019
Regimen
PEME+PEMB(MNT)
Cancer Type:
Lung,
Non-Small Cell
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Palliative
Funding:
New Drug Funding Program
Pembrolizumab - In Combination with Platinum and Pemetrexed for First Line Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Show More
Show more tags
, Show Less
Show fewer tags
Drugs Used:
pembrolizumab
,
pemetrexed
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2023
Regimen
PNAT
Cancer Type:
Hematologic,
Leukemia - Acute Lymphoblastic (ALL)
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Curative, Palliative
Funding:
Exceptional Access Program
ponatinib - For the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), according to specific clinical criteria
Show More
Show more tags
, Show Less
Show fewer tags
Drugs Used:
ponatinib
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2023
Patient Reported Outcomes & Symptom Management Program
Regimen
PAZO
Cancer Type:
Genitourinary,
Renal cell / Kidney
Show More
Show more tags
, Show Less
Show fewer tags
Intent:
Palliative
Funding:
Exceptional Access Program
pazopanib - For first-line treatment of advanced or metastatic renal cell carcinoma of clear cell histology in patients with good performance status (ECOG 0-1), with specific criteria
Show More
Show more tags
, Show Less
Show fewer tags
Drugs Used:
pazopanib
...
Show more tags
, Collapse
Show fewer tags
Quick Link(s):
Regimen Monograph
Dec 2024
Pages
« First
‹ Previous
…
6
7
8
9
10
11
12
13
14
Next ›
Last »